Gene suppression of HuR using knockdown (e.g., shRNA, siRNA) and knockout (e.g., CRISPR/Cas9) methods has been shown to inhibit tumor growth both in vitro and in vivo (189). Here, ELAVL1 is linked to neoplasm.